Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

European researchers identify genetic determinants of deafness

28.08.2003


September 1 is World Deafness Day



Deafness is a real and often underestimated health problem in Europe: 6% of the European population suffer of hearing impairment. It is now known that over 50% of all hearing impairments is caused by genetic factor. Over the last 7 years, the European Commission has channelled more than €10 million into research on different aspects of deafness. One particular project receiving support from the European Commission identified several genes which when affected lead to inherited deafness in humans. These discoveries increase significantly our understanding of the hearing process and open avenues for new therapies for deafness.

On the occasion of World Deafness Day on 1 September, European Research Commissioner Philippe Busquin said: “The number of patients suffering of hearing impairment is constantly growing due to increased noise pollution and to an ageing population. So far, aside from hearing aids, there is no remedy for deafness. Developing new therapies requires the best researchers from different countries and disciplines to work together in order to improve our knowledge on the hearing process and to identify the causes leading to deafness. This is precisely what the EU is making to happen through its research programmes.”


Deafness is a real heath problem in Europe

In Europe, 22.5 million individuals suffer form hearing impairment with 2 million profoundly deaf. In children, deafness impedes language acquisition and generates learning difficulties. In adults, if often leads to severe disruption of social links which very frequently results in depression. All together, in Europe, the financial cost of hearing impairment has been estimated to be €78 billion per year (based on average of €3,500 per patient annual costs for special education, speech therapy, hearing aids, physician and specialists fees, and other expenses). This is more than the combined economic costs of epilepsy, multiple sclerosis, spinal injury, stroke and Parkinson’s disease. Furthermore, this figure is likely to grow continuously in time due to noise pollution and ageing. Hearing loss is the third leading chronic disability following arthritis and hypertension.

Research on deafness is a European priority

The European Commission is supporting research on deafness for many years. In particular, the project “hereditary deafness” co-ordinated by Prof. Christine Petit (Pasteur Institute, Paris, France) allowed substantial progress in the understanding of the hearing process and in the identification of the genetic determinants of deafness. 50 % of the hearing deficiencies have a genetic origin. Importantly, this consortium of leading European researchers identified half of the 36 genes known to be associated with deafness. One of these genes, “connexin 26” was found to be responsible for more than 30% of deafness cases in Europe. The identification of the genetic determinants is crucial for diagnosing the underlying causes of deafness. These diagnostic tools are now available and can be used in a very large proportion of cases of deafness to identify the genetic origin of their hearing impairment.

Furthermore, this research has considerably increased our knowledge of the hearing mechanism: i.e. how a wave sound can be transmitted from the outer ear to the inner ear and be sent to the brain as an electrical signal. These discoveries open new avenues for developing innovative therapies for deafness. Several mouse models have also been developed mimicking the human hearing impairments. They will be very useful for testing new therapeutic approaches.

All together, this European effort has considerably increased our knowledge on this important health problem. However, we are still far from understanding the complete picture and most importantly there is still a long way before having new potential therapies for deafness. This is why the European Commission has made deafness a research priority in the second call for proposals of the Sixth Framework Programme published in July 2003, inviting large European projects to study the hearing process and deafness.

Jacques Remacle | alfa

More articles from Health and Medicine:

nachricht A promising target for kidney fibrosis
21.04.2017 | Brigham and Women's Hospital

nachricht Stem cell transplants: activating signal paths may protect from graft-versus-host disease
20.04.2017 | Technische Universität München

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Deep inside Galaxy M87

The nearby, giant radio galaxy M87 hosts a supermassive black hole (BH) and is well-known for its bright jet dominating the spectrum over ten orders of magnitude in frequency. Due to its proximity, jet prominence, and the large black hole mass, M87 is the best laboratory for investigating the formation, acceleration, and collimation of relativistic jets. A research team led by Silke Britzen from the Max Planck Institute for Radio Astronomy in Bonn, Germany, has found strong indication for turbulent processes connecting the accretion disk and the jet of that galaxy providing insights into the longstanding problem of the origin of astrophysical jets.

Supermassive black holes form some of the most enigmatic phenomena in astrophysics. Their enormous energy output is supposed to be generated by the...

Im Focus: A Quantum Low Pass for Photons

Physicists in Garching observe novel quantum effect that limits the number of emitted photons.

The probability to find a certain number of photons inside a laser pulse usually corresponds to a classical distribution of independent events, the so-called...

Im Focus: Microprocessors based on a layer of just three atoms

Microprocessors based on atomically thin materials hold the promise of the evolution of traditional processors as well as new applications in the field of flexible electronics. Now, a TU Wien research team led by Thomas Müller has made a breakthrough in this field as part of an ongoing research project.

Two-dimensional materials, or 2D materials for short, are extremely versatile, although – or often more precisely because – they are made up of just one or a...

Im Focus: Quantum-physical Model System

Computer-assisted methods aid Heidelberg physicists in reproducing experiment with ultracold atoms

Two researchers at Heidelberg University have developed a model system that enables a better understanding of the processes in a quantum-physical experiment...

Im Focus: Glacier bacteria’s contribution to carbon cycling

Glaciers might seem rather inhospitable environments. However, they are home to a diverse and vibrant microbial community. It’s becoming increasingly clear that they play a bigger role in the carbon cycle than previously thought.

A new study, now published in the journal Nature Geoscience, shows how microbial communities in melting glaciers contribute to the Earth’s carbon cycle, a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Expert meeting “Health Business Connect” will connect international medical technology companies

20.04.2017 | Event News

Wenn der Computer das Gehirn austrickst

18.04.2017 | Event News

7th International Conference on Crystalline Silicon Photovoltaics in Freiburg on April 3-5, 2017

03.04.2017 | Event News

 
Latest News

New quantum liquid crystals may play role in future of computers

21.04.2017 | Physics and Astronomy

A promising target for kidney fibrosis

21.04.2017 | Health and Medicine

Light rays from a supernova bent by the curvature of space-time around a galaxy

21.04.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>